OXB Partners with Aura Biosciences for Phase 3 Cancer Drug Development
OXB has confirmed its manufacturing and supply partnership with Aura Biosciences to support the late-stage development of belzupacap sarotalocan (bel-sar), an investigational treatment…
Read More...
Read More...
